Portuguese Researchers Make Progress in Developing Immunotherapy Targeting Colorectal Cancer
Portuguese researchers working to advance colorectal cancer treatment have discovered a new type of white blood cell that could open the door to more effective forms of immunotherapy. The white blood cells’ robust tumor cell identification and eradication abilities could enable researchers to develop a novel immunotherapy to combat colorectal cancer, currently the second most common type of cancer in Portugal and the third most commonly diagnosed cancer worldwide. The research was led by Gulbenkian Institute of Molecular Medicine (GIMM) Foundation lead investigator Bruno Silva-Santos and researcher Sofia Mensurado, who demonstrated that this new cell therapy is more effective at…